CLINICAL_TRIALS
trial_result
· 2020-11-12
Clinical Trial Update: PI-88 in Hepatocellular Carcinoma After Hepatectomy [Phase 2]
Summary
Phase 2 clinical trial update for PI-88 in hepatocellular carcinoma after hepatectomy has completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cellxpert Biotechnology Corp. | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED | Results posted: 2020-11-12